Evaluation of treatment effectiveness Sample Clauses

Evaluation of treatment effectiveness. Xxxx reported that the treatment intervention led to a reduction in the frequency of her intrusions and the level of consequent distress she experienced. This was also demonstrated by a reduction in her total distress score on The Obsessive Compulsive Inventory (OCI; Foa et al, 1998) from 6, at first session, to 2 at the final session (table 3). Although a recent study indicates that the OCI is valid for use with older adults (Xxxxxxxx et al., 2014) the disparity between the levels of clinical symptoms displayed and reported by Xxxx and her self-report on the OCI suggests that it was not a valid representation of her clinical symptoms. This is because the OCI’s cut off for clinical caseness is 60 and Xxxx xxxx well below this point, despite demonstrating multiple OCD symptoms and acute distress in response, which interfered with her daily life. This is likely due to the impact of her language and culture on her interpretation of the questionnaire items, despite her being supported to complete the questionnaire. There was also a reduction in her general distress indicated by a reduction in her scores on The Clinical Outcomes in Routine Evaluation - 10 (CORE-10) from 18 at assessment, indicating moderate levels of distress, to 6 at the final session, indicating non clinical levels of distress (table 1). The Geriatric Depression Scale (GDS) (Sheikh & Xxxxxxxx, 1986) also showed a reduction in depression from moderate levels (12/15) at assessment, to mild levels (8/15) at the final session. There was however no reduction in her levels of anxiety as measured by the Geriatric Anxiety Inventory (GAI) (Pachana et al., 2007) which remained at a severe level throughout treatment (20/20). Table 1: Outcome measures at the beginning, middle and end of treatment Measure Beginning Middle End Core 10 18 moderate distress 14 Mild distress 6 non clinical levels of distress GDS 12/15 Moderate depression 9/15 Mild depression 8/15 Mild depression GAI 20/20 Severe Anxiety 20/20 Severe Anxiety 20/20 Severe Anxiety OCI (distress) 6 non clinical levels 4 non clinical levels 2 non clinical levels
Sample 1
AutoNDA by SimpleDocs

Related to Evaluation of treatment effectiveness

  • Amendment Effectiveness This Amendment shall become effective as of the first date (the “First Refinancing Amendment Effective Date”) on which the following conditions have been satisfied:

  • Filing and Effectiveness The Merger shall become effective when the following actions shall have been completed:

  • Term and Effectiveness This Agreement shall become effective as of the first date written above. Once effective, this Agreement shall remain in effect for two years, and thereafter shall continue automatically for successive one-year periods; provided that such continuance is specifically approved at least annually by: (i) the vote of the Board, or by the vote of a majority of the outstanding voting securities of the Company and (ii) the vote of a majority of the Independent Directors, in accordance with the requirements of the 1940 Act, or as otherwise permitted under Section 15 of the 1940 Act.

  • Integration; Effectiveness This Agreement, the other Loan Documents, and any separate letter agreements with respect to fees payable to the Administrative Agent or any L/C Issuer, constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto, and thereafter shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

  • Effectiveness, Duration and Termination of Agreement This Agreement shall become effective as of the first date above written. This Agreement shall remain in effect for two years, and thereafter shall continue automatically for successive annual periods, provided that such continuance is specifically approved at least annually by (a) the vote of the Corporation’s Board of Directors, or by the vote of a majority of the outstanding voting securities of the Corporation and (b) the vote of a majority of the Corporation’s Directors who are not parties to this Agreement or “interested persons” (as such term is defined in Section 2(a)(19) of the Investment Company Act) of any such party, in accordance with the requirements of the Investment Company Act. This Agreement may be terminated at any time, without the payment of any penalty, upon 60 days written notice, by the vote of a majority of the outstanding voting securities of the Corporation, or by the vote of the Corporation’s Directors or by the Adviser. This Agreement will automatically terminate in the event of its “assignment” (as such term is defined for purposes of Section 15(a)(4) of the Investment Company Act). The provisions of Section 8 of this Agreement shall remain in full force and effect, and the Adviser and its representatives shall remain entitled to the benefits thereof, notwithstanding any termination or expiration of this Agreement. Further, notwithstanding the termination or expiration of this Agreement as aforesaid, the Adviser shall be entitled to any amounts owed under Section 3 of this Agreement through the date of termination or expiration.

  • Notice of Effectiveness Within two (2) Business Days after the Registration Statement which includes the Registrable Securities is ordered effective by the Commission, the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies to the Holders whose Registrable Securities are included in such Registration Statement) confirmation that the Registration Statement has been declared effective by the Commission in the form attached hereto as Exhibit B.

  • EFFECTIVENESS, DURATION AND TERMINATION (a) This Agreement shall become effective with respect to a Fund immediately upon the later of approval by a majority of the Trust's trustees who are not parties to this Agreement or interested persons of any such party (other than as trustees of the Trust) and, if required by applicable law, by a vote of a majority of the outstanding voting securities of the Fund.

  • Effectiveness and Termination Upon the execution of this Agreement by the parties hereto, this Agreement shall become effective in this form as of the Time of Sale, and may be terminated at any time by any party upon thirty (30) days prior written notice to the other parties unless earlier terminated: (i) in accordance with Section 2(a)(i); (ii) upon notice to the Authorized Participant by the Trustee in the event of a breach by the Authorized Participant of this Agreement or the procedures described or incorporated herein; (iii) immediately in the circumstances described in Section 18(j); or (iv) at such time as the Trust is terminated pursuant to the Trust Agreement.

  • Counterparts; Integration; Effectiveness This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement and the other Loan Documents constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.

  • Termination Effectiveness 36 Section 9.01 Termination............................................................36 Section 9.02 Effect.................................................................37 Section 9.03

Time is Money Join Law Insider Premium to draft better contracts faster.